Co-Diagnostics, Inc.

CODX

$1.09

Name : Co-Diagnostics, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $7,609,638.00

EPSttm : -25.89

Co-Diagnostics, Inc.

$1.09

5.22%

$0.06

CODX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.39

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

1.19

EPS Last/This Y

32.15

EPS This/Next Y

2.27

Price

1.1

Target Price

Analyst Recom

Performance Q

-64.38

Upside

-72,219.3%

Beta

2.9

Ticker: CODX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	CODX	1.23	N/A	N/A	0
2026-08-31	CODX	1.23	N/A	N/A	0
2026-09-02	CODX	1.14	N/A	N/A	0
2026-09-03	CODX	1.16	N/A	N/A	0
2026-09-04	CODX	1.16	N/A	N/A	0
2026-09-08	CODX	1.12	N/A	N/A	0
2026-09-09	CODX	1.13	N/A	N/A	0
2026-09-10	CODX	1.11	N/A	N/A	0
2026-09-11	CODX	1.13	N/A	N/A	0
2026-09-14	CODX	1.12	N/A	N/A	0
2026-09-15	CODX	1.15	N/A	N/A	0
2026-09-16	CODX	0.9501	N/A	N/A	0
2026-09-17	CODX	0.9446	N/A	N/A	0
2026-09-18	CODX	0.9401	N/A	N/A	0
2026-09-21	CODX	1	N/A	N/A	0
2026-09-22	CODX	1.08	N/A	N/A	0
2026-09-23	CODX	1.09	N/A	N/A	0
2026-09-24	CODX	1.14	N/A	N/A	0
2026-09-25	CODX	1.0901	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	CODX	1.21	73.2	-	-3.10
2026-08-31	CODX	1.23	73.2	-	-3.10
2026-09-01	CODX	1.18	73.2	-	-3.10
2026-09-02	CODX	1.14	73.2	-	-3.10
2026-09-03	CODX	1.16	73.2	-	-3.10
2026-09-04	CODX	1.16	73.2	-	-3.10
2026-09-08	CODX	1.12	73.2	-	-3.10
2026-09-09	CODX	1.11	73.2	-	-3.10
2026-09-10	CODX	1.10	73.2	-	-3.10
2026-09-11	CODX	1.12	73.2	-	-3.10
2026-09-14	CODX	1.11	73.2	-	-3.10
2026-09-15	CODX	1.14	73.2	-	-3.10
2026-09-16	CODX	1.14	73.2	-	-3.10
2026-09-17	CODX	0.95	73.2	-	-3.10
2026-09-18	CODX	0.98	73.2	-	-3.10
2026-09-21	CODX	1.01	73.2	-	-3.10
2026-09-22	CODX	1.10	73.2	-	-3.10
2026-09-23	CODX	1.09	73.2	-	-3.10
2026-09-24	CODX	1.14	73.2	-	-3.10
2026-09-25	CODX	1.10	73.2	-	-3.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	CODX	0.00	11.27	5.98
2026-08-31	CODX	0.00	11.27	5.24
2026-09-01	CODX	0.00	11.27	5.24
2026-09-02	CODX	0.00	11.27	5.24
2026-09-03	CODX	0.00	11.27	5.24
2026-09-04	CODX	0.00	11.27	5.24
2026-09-08	CODX	0.00	10.93	5.24
2026-09-09	CODX	0.00	10.93	5.24
2026-09-10	CODX	0.00	10.93	5.24
2026-09-11	CODX	0.00	10.93	3.10
2026-09-14	CODX	0.00	10.93	3.09
2026-09-15	CODX	0.00	10.93	3.09
2026-09-16	CODX	0.00	10.93	3.09
2026-09-17	CODX	0.00	10.93	3.09
2026-09-18	CODX	0.00	10.93	3.09
2026-09-21	CODX	0.00	10.98	3.09
2026-09-23	CODX	0.00	10.98	3.09
2026-09-24	CODX	0.00	10.98	3.09
2026-09-25	CODX	0.00	10.98	4.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.46

Avg. EPS Est. Current Quarter

-1.25

Avg. EPS Est. Next Quarter

-0.27

Insider Transactions

Institutional Transactions

10.98

Beta

2.9

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.7

Max Drawdown 5-Year %

-99.7

Target Price

P/E

Forward P/E

PEG

P/S

14.96

P/B

0.42

P/Free Cash Flow

EPS

-22.46

Average EPS Est. Cur. Y

-3.1

EPS Next Y. (Est.)

-0.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9100

Relative Volume

0.44

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

10.4

EPS 1 30Days Diff

10.4

EBIT Estimation

◆ CODX Healthcare

$1.09

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

9/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

41.3

Range 1M

49.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

28/30

Estimates

0/20

Inst/Vol

5/15

Options

0/10

EPS Yr

91.2%

EPS NY

73.2%

52W%

0.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +267% upside

Quality

2/30

Valuation

16/30

Growth

20/25

Stability

6/10

LT Trend

1/5

Upside

+267%

Quality

CODX — P/E HistoricalDiagnostics & Research

Co-Diagnostics, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 115

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

CODX

Latest News

—

Caricamento notizie per CODX…

stock quote shares CODX – Co-Diagnostics, Inc. Stock Price stock today

news today CODX – Co-Diagnostics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CODX – Co-Diagnostics, Inc. yahoo finance google finance

stock history CODX – Co-Diagnostics, Inc. invest stock market

stock prices CODX premarket after hours

ticker CODX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CODX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y